News | Atherectomy Devices | January 10, 2022

Cardiovascular Systems Inc Recalls Wirion Embolic Protection Device Due Filters Breaking During Retrieval

The CSI Wirion atherectomy embolic protection device is being recalled due to complaints of filter breakage during retrieval.

The CSI Wirion atherectomy embolic protection device is being recalled due to complaints of filter breakage during retrieval.


January 10, 2022 — Cardiovascular Systems Inc. (CSI) is recalling the Wirion atherectomy embolic protection device system due to complaints of filter breakage during retrieval. Under certain circumstances, such as when the filter basket is too full, the filter assembly may become difficult to withdraw. In this situation, withdrawal may cause the Wirion system filter component to tear or separate, which may result in series adverse events such as embolization or the need for additional medical procedures.

Cardiovascular Systems Inc. has received reports of nine device malfunctions, but no reports of death related to this device issue.

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

The Wirion system is used to hold debris or blood clots removed from the lower limbs during atherectomy.

There are 697 devices being recalled in the U.S. This includes all products and lots from Jan. 3, 2021 to Aug. 16, 2021. Distribution of the devices occurred between March 22, 2021 to Nov. 15, 2021. 

The company initiated the recall Nov. 22, 2021, when CSI sent an urgent notification recall letter to customers instructing them remove the device from distribution and return the device to Cardiovascular Systems Inc.

Customers in the U.S. with questions about this recall should contact Cardiovascular Systems Inc. by phone at (65) 259-2800.

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.

For more information: www.csi360.com

Find more atherectomy systems news

FDA Issues Final Guidance on Peripheral Vascular Atherectomy Devices
 


Related Content

News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
Subscribe Now